NGLY1 Deficiency is an autosomal recessive congenital disorder that has been identified in less than 100 individuals. Most individuals with NGLY1 Deficiency display hyperkinetic movement disorders, including choreiform, athetoid, dystonic myoclonic, dyskinetic, and dysmetric movements. Developing a consistent and concise consensus on the classification and evaluation of tremors is essential to forward the research and treatment of tremors. It has also been reported that some individuals with NGLY1 Deficiency demonstrate tremor, but such tremor has never been formally investigated. The primary objective of this study is to determine if an individual with NGLY1 Deficiency demonstrates an identifiable tremor during a series of arm movements and, if so, describe the frequency and power characteristics of that tremor. Arm movement kinematics were obtained using a 16-camera Vicon system, and time series trajectory waveforms for three planes of a marker placed on the hand were developed. Custom MATLAB scripts were utilized to compute Fast Fourier Transformations of the data within the identified waveform segments. A mean frequency of 2.30 Hz (SD = 1.05) with a mean power of 5.02 |P1(f)| (SD = 4.63) suggests that our participant’s kinematic data did display a persistent tremor in both hands across all tasks and movement planes. Analyses of the reaching hand and the non-reaching hand suggest the participant displayed an action tremor in both postural and intention (kinetic) tremors. Future directions should include assessing additional individuals with NGLY1 Deficiency to determine if the tremor is a distinguishable disorder behavior. Additionally, evaluating other anatomical sites, such as the elbow, head, and lower limbs, would provide further insights into the characteristics of this tremor.
References
[1]
Pandey, A., Adams, J.M., Han, S.Y. and Jafar-Nejad, H. (2022) NGLY1 Deficiency, a Congenital Disorder of Deglycosylation: From Disease Gene Function to Pathophysiology. Cells, 11, 1155. https://doi.org/10.3390/cells11071155
[2]
Lipiński, P., Bogdańska, A., Różdżyńska-Świątkowska, A., Wierzbicka-Rucińska, A. and Tylki-Szymańska, A. (2020) NGLY1 Deficiency: Novel Patient, Review of the Literature and Diagnostic Algorithm. JIMD Reports, 51, 82-88. https://doi.org/10.1002/jmd2.12086
[3]
Dabaj, I., et al. (2021) NGLY1 Deficiency: A Rare Newly Described Condition with a Typical Presentation. Life, 11, 187. https://doi.org/10.3390/life11030187
[4]
Lipari Pinto, P., et al. (2020) NGLY1 Deficiency—A Rare Congenital Disorder of Deglycosylation. JIMD Reports, 53, 2-9. https://doi.org/10.1002/jmd2.12108
[5]
Lam, C., Wolfe, L., Need, A., Shashi, V. and Enns, G. (2023) NGLY1-Related Congenital Disorder of Deglycosylation. In: Adam, M.P., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J., Gripp, K.W. and Amemiya, A., Eds., GeneReviews®. University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/books/NBK481554/
[6]
Stanclift, C.R., et al. (2022) NGLY1 Deficiency: Estimated Incidence, Clinical Features, and Genotypic Spectrum from the NGLY1 Registry. Orphanet Journal of Rare Diseases, 17, Article No. 440. https://doi.org/10.1186/s13023-022-02592-3
[7]
Need, A.C., et al. (2012) Clinical Application of Exome Sequencing in Undiagnosed Genetic Conditions. Journal of Medical Genetics, 49, 353-361. https://doi.org/10.1136/jmedgenet-2012-100819
[8]
Bhatia, K.P., et al. (2018) Consensus Statement on the Classification of Tremors from the Task Force on Tremor of the International Parkinson and Movement Disorder Society: IPMDS Task Force on Tremor Consensus Statement. Movement Disorders, 33, 75-87. https://doi.org/10.1002/mds.27121
[9]
Chang, C.A., Wei, X., Martin, S.R., Sinasac, D.S. and Al-Hertani, W. (2019) Transiently Elevated Plasma Methionine, Sadenosylmethionine and Sadenosylhomocysteine: Unreported Laboratory Findings in a Patient with NGLY1 Deficiency, a Congenital Disorder of Deglycosylation. JIMD Reports, 49, 21-29. https://doi.org/10.1002/jmd2.12064
[10]
Hope, K.A., Berman, A.R., Peterson, R.T. and Chow, C.Y. (2022) An in vivo Drug Repurposing Screen and Transcriptional Analyses Reveals the Serotonin Pathway and GSK3 as Major Therapeutic Targets for NGLY1 Deficiency. PLOS Genetics, 18, e1010228. https://doi.org/10.1371/journal.pgen.1010228
[11]
Hess, C.W. and Pullman, S.L. (2012) Tremor: Clinical Phenomenology and Assessment Techniques. Tremor and Other Hyperkinetic Movements, 2, Article No. 2. https://doi.org/10.5334/tohm.115
[12]
Krishna, R., Pathirana, P.N., Horne, M., Power, L. and Szmulewicz, D.J. (2019) Quantitative Assessment of Cerebellar Ataxia, through Automated Limb Functional Tests. Journal of NeuroEngineering and Rehabilitation, 16, Article No. 31. https://doi.org/10.1186/s12984-019-0490-3
[13]
Morgan, K.D. and Noehren, B. (2018) Identification of Knee Gait Waveform Pattern Alterations in Individuals with Patellofemoral Pain Using Fast Fourier Transform. PLOS ONE, 13, e0209015. https://doi.org/10.1371/journal.pone.0209015
[14]
Delacre, M., Lakens, D. and Leys, C. (2022) Correction: Why Psychologists Should by Default Use Welch’s t-Test Instead of Student’s t-Test. International Review of Social Psychology, 35, 21. https://doi.org/10.5334/irsp.661
